Izun Pharmaceuticals
Amy joined Izun in 2006, initially as Director of the R&D and QC Laboratory, and has since added Director of Production to her responsibilities. Amy obtained her Master’s degree from Harvard University and her PhD from Tel Aviv University in Israel, with post-doctoral fellowships at both Stanford University and the Weizmann Institute of Science in Rehovot, Israel.
Amy brings to Izun rich experience in academic research and in managerial positions, both in academia and in the private sector. Dr. Rosenbluh holds a patent and has published a chapter in a book as well as numerous articles.
This person is not in any teams
This person is not in any offices
Izun Pharmaceuticals
Izun Pharmaceuticals develops non-steroidal topical oral anti-inflammatory therapies for periodontal treatments.